StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3067% below fair value
$26.23−0.87 (-3.21%)

Close on Nov 19, 2026Market cap $1.51BP/E –Yield –

Enovis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Enovis's revenue for the twelve months ending Jul 3, 2026 was $2.30B, up 4.9% year over year. For fiscal 2025 it was $2.25B, up 6.7% from the year before. Over ten years it grew -4.1% a year on average. The highest annual figure on record is $4.62B in fiscal 2014.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.25B+6.7%
FY2024Dec 31, 2024$2.11B+23.5%
FY2023Dec 31, 2023$1.71B+9.2%
FY2022Dec 31, 2022$1.56B+9.6%
FY2021Dec 31, 2021$1.43B+27.3%
FY2020Dec 31, 2020$1.12B-66.3%
FY2019Dec 31, 2019$3.33B+51.7%
FY2018Dec 31, 2018$2.19B+13.2%
FY2017Dec 31, 2017$1.94B-39.2%
FY2016Dec 31, 2016$3.19B-7.2%
FY2015Dec 31, 2015$3.43B-25.7%
FY2014Dec 31, 2014$4.62B+9.9%
FY2013Dec 31, 2013$4.21B+7.5%
FY2012Dec 31, 2012$3.91B+464.5%
FY2011Dec 31, 2011$693.39M+27.9%
FY2010Dec 31, 2010$541.99M+3.2%
FY2009Dec 31, 2009$525.02M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 3, 2026$582.78M+3.2%
Q1 FY2026Apr 3, 2026$589.15M+5.4%
Q4 FY2025Dec 31, 2025$575.76M+2.6%
Q3 FY2025Oct 3, 2025$548.91M+8.6%
Q2 FY2025Jul 4, 2025$564.55M+7.5%
Q1 FY2025Apr 4, 2025$558.83M+8.2%
Q4 FY2024Dec 31, 2024$560.98M+23.3%
Q3 FY2024Sep 27, 2024$505.22M+21.0%
Q2 FY2024Jun 28, 2024$525.16M+22.6%
Q1 FY2024Mar 29, 2024$516.27M+27.1%
Q4 FY2023Dec 31, 2023$455.02M+11.3%
Q3 FY2023Sep 29, 2023$417.52M+8.8%
Q2 FY2023Jun 30, 2023$428.50M+8.4%
Q1 FY2023Mar 31, 2023$406.15M+8.2%
Q4 FY2022Dec 31, 2022$408.71M+2.4%
Q3 FY2022Sep 30, 2022$383.81M+6.6%
Q2 FY2022Jul 1, 2022$395.12M+10.9%
Q1 FY2022Apr 1, 2022$375.46M+20.7%
Q4 FY2021Dec 31, 2021$399.06M-51.8%
Q3 FY2021Oct 1, 2021$359.92M-55.3%
Q2 FY2021Jul 2, 2021$356.12M-42.6%
Q1 FY2021Apr 2, 2021$311.08M-61.9%
Q4 FY2020Dec 31, 2020$828.12M-6.8%
Q3 FY2020Oct 2, 2020$805.93M-4.8%
Q2 FY2020Jul 3, 2020$620.36M-31.7%
Q1 FY2020Apr 3, 2020$816.36M+19.4%
Q4 FY2019Dec 31, 2019$888.37M+54.5%
Q3 FY2019Sep 27, 2019$846.52M+61.5%
Q2 FY2019Jun 28, 2019$908.65M+62.0%
Q1 FY2019Mar 29, 2019$683.92M+28.2%
Q4 FY2018Dec 31, 2018$574.93M-34.2%
Q3 FY2018Sep 28, 2018$524.02M-37.9%
Q2 FY2018Jun 29, 2018$560.86M-33.9%
Q1 FY2018Mar 31, 2018$533.27M-27.3%
Q4 FY2017Dec 31, 2017$874.08M+7.6%
Q3 FY2017Sep 29, 2017$844.51M+10.2%
Q2 FY2017Jun 30, 2017$847.96M–
Q1 FY2017Mar 31, 2017$733.63M–
Q4 FY2016Dec 31, 2016$812.41M–
Q3 FY2016Sep 30, 2016$766.52M–

More Enovis figures

See a number that looks wrong?